Key facts
- Notable investors include University Avenue Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Kitsa
- ·The full record, as it builds
Funding rounds
No funding rounds for Kitsa are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Kitsa
Developer of a clinical trials database platform designed to streamline site selection with a comprehensive database of trial sites, featuring demographics, performance metrics, and AI powered matching. The company's platform offers to automate site selection, discover unique sites, online workflows, self service tools, and an online repository, bridging the gap between sponsors and sites, making clinical trials accessible, enabling clinical trial sponsors and clinical research sites to standardize and speed up trial planning and documentation tasks while reducing manual effort.
- Sector
- Healthcare
- HQ
- Berkeley Heights, NJ, United States
- Founded
- 2024
- Employees
- 18
- Website
- kitsa.com/
- Ownership
- Privately Held (backing)
Kitsa doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Kitsa shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Kitsa in its N-PORT filings yet. We sweep new filings monthly.